中华麻醉学杂志2024,Vol.44Issue(12) :1476-1479.DOI:10.3760/cma.j.cn131073.20240403.01215

复合阿芬太尼时环泊酚用于不同BMI患者胃镜检查术麻醉效力的比较

Comparison of anesthetic potency of ciprofol combined with alfentanil in patients with different BMIs during gastroscopy

黄瑾 张珈硕 王晟昱 韩亚楠 姜卜维 马凤丹 王春光
中华麻醉学杂志2024,Vol.44Issue(12) :1476-1479.DOI:10.3760/cma.j.cn131073.20240403.01215

复合阿芬太尼时环泊酚用于不同BMI患者胃镜检查术麻醉效力的比较

Comparison of anesthetic potency of ciprofol combined with alfentanil in patients with different BMIs during gastroscopy

黄瑾 1张珈硕 1王晟昱 1韩亚楠 1姜卜维 1马凤丹 1王春光1
扫码查看

作者信息

  • 1. 保定市第一中心医院麻醉科,保定 071000
  • 折叠

摘要

目的 比较复合阿芬太尼时环泊酚用于不同BMI患者无痛胃镜检查术的麻醉效力.方法 选取保定市第一中心医院2023年10月至12月择期行无痛胃镜检查术患者,年龄18~64岁,BMI 18~36 kg/m2,ASA分级Ⅰ或Ⅱ级,根据患者BMI分为3组:体质量正常组(18 kg/m2≤BMI<24kg/m2)、超重组(24kg/m2≤BMI<28 kg/m2)和肥胖组(BMI≥28 kg/m2).采用抛偏倚硬币设计(BCD)法确定无痛胃镜检查中环泊酚95%有效剂量(ED95).静脉注射阿芬太尼5 μg/kg和环泊酚行麻醉诱导,待患者睫毛反射消失、下颌松弛、改良警觉/镇静评分≤1分后进行胃镜检查术.环泊酚初始剂量0.2 mg/kg,剂量梯度为0.04 mg/kg,若注射环泊酚3 min后改良警觉/镇静评分仍>1分或进镜时患者出现体动、呛咳、吞咽等影响操作的反应为阳性反应,否则为阴性反应.若发生阳性反应,下一例患者升高一个剂量梯度;若发生阴性反应,下一例患者95%的概率接受相同剂量,5%的概率接受降低一个剂量梯度的剂量,直至完成40例.结果 体质量正常组、超重组、肥胖组环泊酚ED95(95%置信区间)分别为0.266(0.246~0.285)mg/kg、0.218(0.189~0.244)mg/kg、0.191(0.156~0.220)mg/kg,超重组和肥胖组环泊酚ED95低于体质量正常组(P<0.05).结论 超重和肥胖可增加胃镜检查术患者环泊酚的麻醉效力.

Abstract

Objective To compare the anesthetic potency of ciprofol combined with alfentanil in patients with different body mass indexes(BMIs)during gastroscopy.Methods American Society of Anes-thesiologists Physical Status classification Ⅰ or Ⅱ patients,aged 18-64 yr,with a BMI of 18-36 kg/m2,un-dergoing elective painless gastroscopy at Baoding First Central Hospital from October to December 2023,were divided into 3 groups:normal group(18 kg/m2≤BMI<24 kg/m2),overweight group(24 kg/m2 BMI<28 kg/m2)and obesity group(BMI ≥28 kg/m2).The 95%effective dose(ED95)of ciprofol during painless gastroscopy was determined by the biased coin design.Alfentanyl 5 μg/kg and ciprofol were intrave-nously injected for anesthesia induction.Gastroscopy was performed after the patient's eyelash reflex disap-peared,the jaw muscle was relaxed and the Modified Observer's Assessment of Alertness/Sedation Scale score ≤ 1.The initial dose of ciprofol was 0.2 mg/kg with a dose gradient of 0.04 mg/kg.The positive re-sponse were defined as the Modified Observer's Assessment of Alertness/Sedation Scale score still>1 after 3 min of ciprofol injection or any other responses affecting the procedure,such as body movement,bucking,or swallowing during insertion of the endoscope.If the response was positive,the next patient received a higher dose of ciprofol,or conversely if negative,the next patient received the same dose(95%probability)or a lower dose(5%probability).Each group was completed with 40 cases.Results The ED95 and 95%confidence intervals of ciprofol in normal,overweight and obese groups were 0.266(0.246,0.285)mg/kg,0.218(0.189,0.244)mg/kg,0.191(0.156,0.220)mg/kg,respectively.The ED95 of ciprofol was signif-icantly lower in overweight and obese groups than in normal group(P<0.05).Conclusions Overweight and obesity can increase the anesthetic potency of ciprofol in patients undergoing gastroscopy.

关键词

体重变化/环泊酚/阿芬太尼/胃镜检查/剂量效应关系,药物

Key words

Body weight changes/Ciprofol/Alfentanyl/Gastroscopy/Dose-effect relation-ship,drug

引用本文复制引用

出版年

2024
中华麻醉学杂志
中华医学会

中华麻醉学杂志

CSTPCDCSCD北大核心
影响因子:1.235
ISSN:0254-1416
段落导航相关论文